Abound Wealth Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210 Sell
4
-1
-20% -$39 ﹤0.01% 1104
2026
Q1
$177 Sell
5
-3
-38% -$93 ﹤0.01% 1265
2025
Q4
$224 Hold
8
﹤0.01% 1135
2025
Q3
$240 Hold
8
﹤0.01% 1065
2025
Q2
$229 Hold
8
﹤0.01% 994
2025
Q1
$265 Sell
8
-2
-20% -$65 ﹤0.01% 900
2024
Q4
$288 Hold
10
﹤0.01% 904
2024
Q3
$280 Hold
10
﹤0.01% 994
2024
Q2
$241 Sell
10
-10
-50% -$245 ﹤0.01% 1052
2024
Q1
$542 Buy
+20
New +$568 ﹤0.01% 870

Other funds holding ALKS

Abound Wealth Management's ALKS Position: Q2 2026 in Review

Abound Wealth Management reduced its Alkermes (ALKS) stake by 20% in Q2 2026, selling an estimated $39 and leaving 4 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Abound Wealth Management first reported a position in ALKS in Q1 2024 and has held it in 10 quarters since. The position peaked at $542 in Q1 2024. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Abound Wealth Management held 4 shares of Alkermes worth $210 as of Q2 2026.
  • Abound Wealth Management sold 1 Alkermes share in Q2 2026, an estimated $39.
  • Alkermes made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1104 holding.
  • Abound Wealth Management first reported a position in Alkermes in Q1 2024 and has held it in 10 quarters since.
  • Abound Wealth Management's Alkermes position peaked at $542 in Q1 2024.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.